Clinical Presentation with High Penetrance in a Korean Family with Pulmonary Arterial Hypertension Associated with a BMPR2 Intron 3 Splice Site Pathogenic Variant
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Pathogenic variants of bone morphogenic protein receptor type 2 gene (BMPR2) are related to the majority of cases of heritable pulmonary arterial hypertension (PAH). Over 400 pathogenic variants have been identified. However, clinical characterization of PAH is still incomplete. We present a case of heritable PAH in a Korean family showing serious clinical presentation with high penetrance. Genetic sequencing revealed a known heterozygous BMPR2 pathogenic variant, c.418+5G>A, at a splice site of intron 3. Serious clinical presentation with high penetrance suggested that the interplay of other factors with pathologic variants might be in genotype-phenotype correlation. Further studies are needed to clarify these issues for the development of personalized medicine approaches for PAH.
Abstract
Pathogenic variants of bone morphogenic protein receptor type 2 gene (BMPR2) are related to the majority of cases of heritable pulmonary arterial hypertension (PAH). Over 400 pathogenic variants have been identified. However, clinical characterization of PAH is still incomplete. We present a case of heritable PAH in a Korean family showing serious clinical presentation with high penetrance. Genetic sequencing revealed a known heterozygous BMPR2 pathogenic variant, c.418+5G>A, at a splice site of intron 3. Serious clinical presentation with high penetrance suggested that the interplay of other factors with pathologic variants might be in genotype-phenotype correlation. Further studies are needed to clarify these issues for the development of personalized medicine approaches for PAH.
참고문헌 (16)
- Farber HW, "Pulmonary arterial hypertension", N Engl J Med, 351, pp.1655~1665 (2004)[DOI]
- Machado RD, "Genetics and genomics of pulmonary arterial hypertension", J Am Coll Cardiol, 54, pp.32~42 (2009)[DOI]
- Machado RD, "Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects", Hum Mutat, 36, pp.1113~1127 (2015)[DOI]
- Leter EM, "Genetic counselling for pulmonary arterial hypertension: a matter of variable variability", Neth Heart J, 19, pp.89~92 (2011)[DOI]
- McLaughlin VV, "Pulmonary arterial hypertension", Circulation, 114, pp.1417~1431 (2006)
- Rosenzweig EB, "Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension", J Heart Lung Transplant, 27, pp.668~674 (2008)[DOI]
- "The human gene mutation database"[URL]
- Austin ED, "Heritable forms of pulmonary arterial hypertension", Semin Respir Crit Care Med, 34, pp.568~580 (2013)[DOI]
- "An introduction to genetic analysis. 7th ed"[URL]
- Machado RD, "BMPR2 haploinsuf ciency as the inherited molecular mechanism for primary pulmonary hypertension", Am J Human Genet, 68, pp.92~102 (2001)[DOI]
- Hoeper MM, "Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry", Int J Cardiol, 168, pp.871~880 (2013)[DOI]
- Loyd JE, "Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension", Am J Respir Crit Care Med, 152, pp.93~97 (1995)[DOI]
- Machado RD, "Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension", Circulation, 111, pp.607~613 (2005)[DOI]
- Chelladurai P, "Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives", Eur Respir Rev, 25, pp.135~140 (2016)[DOI]
- Sztrymf B, "Genes and pulmonary arterial hypertension", Respiration, 74, pp.123~132 (2007)[DOI]
- Galie N, "2015 ESC", ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), 2016, pp.37, 67~119